title: Molecular characterization of guinea pig-adapted variants of Ebola virus.
abstract: Serial passage of initially nonlethal Ebola virus (EBOV) in outbred guinea pigs resulted in the selection of variants with high pathogenicity. Nucleotide sequence analysis of the complete genome of the guinea pig-adapted variant 8mc revealed that it differed from wild-type virus by eight mutations. No mutations were identified in nontranscribed regions, including leader, trailer, and intragenic sequences. Among noncoding regions the only base change was found in the VP30 gene. Two silent base changes were found in the open reading frame (ORF) encoding NP protein. Nucleotide changes resulting in single-amino-acid exchanges were identified in both NP and L genes. Three other mutations found in VP24 caused amino acid substitutions, which are responsible for larger structural changes of this protein, as indicated by an alteration in electrophoretic mobility. A highly pathogenic EBOV variant K5 from another passaging series showed an amino acid substitution at nearly the same location in the VP24 gene, suggesting the importance of this protein in the adaptation process. In addition, sequence variability of the GP gene was found when plaque-purified clones of EBOV-8mc were analyzed. Three of five viral clones showed insertion of one uridine residue at the GP gene-editing site, which led to a significant change in the expression of virus glycoproteins. This observation suggests that the editing site is a hot spot for insertion and deletion of nucleotides, not only at the level of transcription but also of genome replication. Irrespective of the number of uridine residues at the editing site, all plaque-purified clones of EBOV variant 8mc resembled each other in their pathogenicity for guinea pigs, indicating either the absence or only supportive role of mutations in the GP gene on the adaptation process.
authors.affiliation: Institut für Virologie, Philipps-Universität, Robert-Koch-Strasse 17, Marburg, 35037, Germany. Viktor.Volchkov@ens-lyon.fr
authors.forename: V E
authors.initials: VE
authors.lastname: Volchkov
authors.forename: A A
authors.initials: AA
authors.lastname: Chepurnov
authors.forename: V A
authors.initials: VA
authors.lastname: Volchkova
authors.forename: V A
authors.initials: VA
authors.lastname: Ternovoj
authors.forename: H D
authors.initials: HD
authors.lastname: Klenk
mesh_terms: D019943:Amino Acid Substitution; D000818:Animals; D003001:Cloning, Molecular; D004251:DNA Transposable Elements; D029043:Ebolavirus / Q000235:genetics* / Q000254:growth & development* / Q000472:pathogenicity; D014644:Genetic Variation; D006168:Guinea Pigs; D008099:Liver / Q000821:virology*; D017354:Point Mutation; D017393:RNA Editing; D012367:RNA, Viral / Q000235:genetics; D014764:Viral Proteins / Q000235:genetics
chemical_list: D004251:DNA Transposable Elements; D012367:RNA, Viral; C094002:VP24 protein, Marburg virus; D014764:Viral Proteins